EINSATZ DER HOCHDRUCK-FLUESSIGKEITSCHROMATOGRAPHIE ZUR PNA-BESTIMMUNG IN MINERALOELPRODUKTEN = UTILISATION DE LA CHROMATOGRAPHIE LIQUIDE A HAUTE PRESSION POUR LE DOSAGE DES HYDROCARBURES AROMATIQUES POLYCYCLIQUES DANS LES PRODUITS PETROLIERSBERTHOLD I.1974; IN: COMPEND. 74/75. VORTR. 24. HAUPTTAG. DTSCH. GES. MINERALOELWISS. KOHLECHEM.; HAMBURG; 1974; LEINFELDEN; INDUSTRIEVERLAG VON HERNHAUSSEN; DA. 1974; VOL. 2; PP. 732-740; ABS. ANGL.; BIBL. 6 REF.Conference Paper

ANALYTIK DER VERSCHLEISSTEUERUNG = ANALYSE DU CONTROLE DE L'USUREBERTHOLD I.1974; IN: COMPEND. 74/75. VORTR. HAUPTTAG. DTSCH. GES. MINERALOELWISS. KOHLECHEM.; HAMBURG; 1974; LEINFELDEN; INDUSTRIEVERLAG VON HERNHAUSSEN; DA. 1974; VOL. 2; PP. 762-771; ABS. ANGLConference Paper

ANALYSE DU CONTROLE DE L'USUREBERTHOLD I.1976; ; S.L.; DA. 1976; PP. 1-9; DE L'ALLEM.: CONFERENCE. 24EME CONGRES HAUPTTAGUNG DER DEUTSCHEN GESELLSCHAFT FUER MINERALOELWISSENSCHAFT UND KOHLECHEMIE E.V. HAMBOURG, 30 SEPTEMBRE-3 OCTOBRE 1974; INDUSTRIE VERLAG VON KERNHAUSEN, 1974, 2, 762-771, 11 FIG., 7 TABLMiscellaneous

Cardiovascular Disease: Focus on DyslipidemiaGOUNI-BERTHOLD, I.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, issn 1381-6128, 112 p.Serial Issue

Antisense Oligonucleotides for the Treatment of DyslipidemiaGOUNI-BERTHOLD, I; BERTHOLD, H. K.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 950-960, issn 1381-6128, 11 p.Article

Molecular mechanisms explaining the preventive effects of catechins on the development of proliferative diseasesGOUNI-BERTHOLD, I; SACHINIDIS, A.Current pharmaceutical design. 2004, Vol 10, Num 11, pp 1261-1271, issn 1381-6128, 11 p.Article

New Lipid Modulating Drugs: The Role of Microsomal Transport Protein InhibitorsRIZZO, Manfredi; WIERZBICKI, Anthony S.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 943-949, issn 1381-6128, 7 p.Article

Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases : New Developments in the Prevention and Treatment of Vascular Disease: 2GOUNI-BERTHOLD, I; BERTHOLD, H. K.Current pharmaceutical design (Print). 2011, Vol 17, Num 33, pp 3690-3698, issn 1381-6128, 9 p.Article

Lipoprotein(a): Medical Treatment Options for an Elusive MoleculePARHOFER, Klaus G.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 871-876, issn 1381-6128, 6 p.Article

Dyslipidemia Treatment and Cardiovascular Disease in the Renal PatientBURST, Volker; BENZING, Thomas.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 894-907, issn 1381-6128, 14 p.Article

The Role of Vitamin D in Dyslipidemia and Cardiovascular DiseaseZITTERMANN, Armin; GUMMERT, Jan F; BÖRGERMANN, Jochen et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 933-942, issn 1381-6128, 10 p.Article

Plant Sterols and Stanols in the Treatment of Dyslipidemia: New Insights into Targets and Mechanisms Related to Cardiovascular RiskBAUMGARTNER, Sabine; MENSINK, Ronald P; PLAT, Jogchum et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 922-932, issn 1381-6128, 11 p.Article

Lipid-lowering Drug Therapy in Elderly PatientsBERTHOLD, Heiner K; GOUNI-BERTHOLD, Ioanna.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 877-893, issn 1381-6128, 17 p.Article

Immunoglobulins and IgG subclasses in patients with inflammatory bowel diseaseGOUNI-BERTHOLD, I; BAUMEISTER, B; BERTHOLD, H. K et al.Hepato-gastroenterology. 1999, Vol 46, Num 27, pp 1720-1723, issn 0172-6390Article

SREBP-1 c Gene Polymorphism is Associated with Increased Inhibition of Cholesterol-Absorption in Response to Ezetimibe TreatmentBERTHOLD, H. K; LAAKSONEN, R; LEHTIMÄKI, T et al.Experimental and clinical endocrinology & diabetes. 2008, Vol 116, Num 5, pp 262-267, issn 0947-7349, 6 p.Article

Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control studyWEINBRENNER, T; ZITTERMANN, A; GOUNI-BERTHOLD, I et al.European journal of clinical nutrition. 2003, Vol 57, Num 10, pp 1262-1267, issn 0954-3007, 6 p.Article

Physician gender is associated with the quality of type 2 diabetes careBERTHOLD, H. K; GOUNI-BERTHOLD, I; BESTEHORN, K. P et al.Journal of internal medicine. 2008, Vol 264, Num 4, pp 340-350, issn 0954-6820, 11 p.Article

Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral bloodYON KO; KLINZ, M; TOTZKE, G et al.Clinical cancer research. 1998, Vol 4, Num 9, pp 2141-2146, issn 1078-0432Article

The Pluripotential Effects of Hypolipidemic Treatment for Polycystic Ovary Syndrome (PCOS): Dyslipidemia, Cardiovascular Risk Factors and BeyondECONOMOU, Frangiskos; XYRAFIS, Xenofon; CHRISTAKOU, Charikleia et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 908-921, issn 1381-6128, 14 p.Article

Association of the promoter polymorphism -232C/G of the phosphoenolpyruvate carboxykinase gene (PCK1) with Type 2 diabetes mellitusGOUNI-BERTHOLD, I; GIANNAKIDOU, E; FAUST, M et al.Diabetic medicine. 2006, Vol 23, Num 4, pp 419-425, issn 0742-3071, 7 p.Article

The whey fermentation product malleable protein matrix decreases triglyceride concentrations in subjects with hypercholesterolemia: A randomized placebo-controlled trialBERTHOLD, H. K; SCHULTE, D. M; LAPOINTE, J.-F et al.Journal of dairy science. 2011, Vol 94, Num 2, pp 589-601, issn 0022-0302, 13 p.Article

The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German populationGOUNI-BERTHOLD, I; GIANNAKIDOU, E; MÜLLER-WIELAND, D et al.Journal of internal medicine. 2005, Vol 257, Num 3, pp 272-280, issn 0954-6820, 9 p.Article

Short-term stimulation of vascular smooth muscle cells with platelet-derived growth factor (PDGF)-BB and angiotensin II induces [³H]thymidine incorporation without mitosisGOUNI-BERTHOLD, I; BERTHOLD, H. K; SEEWALD, S et al.Scandinavian journal of clinical & laboratory investigation. 2000, Vol 60, Num 8, pp 723-731, issn 0036-5513Article

Cardiovascular Disease and Dyslipidemia: Beyond LDLPÖSS, Janine; CUSTODIS, Florian; WERNER, Christian et al.Current pharmaceutical design (Print). 2011, Vol 17, Num 9, pp 861-870, issn 1381-6128, 10 p.Article

Evidence that lipoproteins are carriers of bioactive factorsSACHINIDIS, A; KETTENHOFEN, R; SEEWALD, S et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 10, pp 2412-2421, issn 1079-5642Article